TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial.

Pieter Sonneveld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.